News
ReNeuron Group plc - Preliminary Results
RNS Number: 5135 J ReNeuron Group plc 29 June 2017. ReNeuron Group plc, a UK- based global leader in the development of cell-based therapeutics, is pleased to announce its preliminary results for the year ended 31 March 2017.. -Pivotal Phase III clinical trial planned to commence in US in early 2018, following positive feedback from the FDA.
RNS Number: 5135 J ReNeuron Group plc 29 June 2017. ReNeuron Group plc, a UK- based global leader in the development of cell-based therapeutics, is pleased to announce its preliminary results for the year ended 31 March 2017.. -Pivotal Phase III clinical trial planned to commence in US in early 2018, following positive feedback from the FDA.